LOVELAND, Colo., Dec. 23,
2022 /PRNewswire/ -- Heska Corporation (NASDAQ:
HSKA - News; "Heska" or the "Company"), a leading
global provider of advanced veterinary diagnostic and specialty
solutions, announced that members of Heska's management team will
participate in the upcoming 41st Annual
J.P. Morgan Healthcare Conference in San
Francisco, CA.
Kevin Wilson, Heska's President
& Chief Executive Officer, will present on Wednesday, January 11, 2023 at 9:45 a.m. Pacific Standard Time. A live audio
webcast of Mr. Wilson's presentation will be available by visiting
Heska J.P. Morgan 2023 Healthcare Conference Webcast. The webcast
and presentation will be archived on the Company's website shortly
after the event and a replay will be available for 90 days
following the conference.
Mr. Wilson and members of Company management will also be
participating in one-on-one meetings on January 11th. To request a meeting,
please contact J.P. Morgan at 1x1@jpmorgan.com or Heska Investor
Relations at investorrelations@heska.com.
For more information regarding the J.P. Morgan 2023 Healthcare
Conference, visit J.P. Morgan Healthcare Conference Website.
About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and
sells advanced veterinary diagnostics, informatics, and specialty
healthcare solutions through its two business segments:
North America and International.
Both segments include Point of Care Lab testing instruments and
consumables, digital imaging products, software and services, data
services, allergy testing and immunotherapy, and single-use
offerings such as in-clinic diagnostic tests and heartworm
preventive products. The North
America segment also includes private label vaccine and
pharmaceutical production for third-parties, primarily for herd
animal health. For more information, please visit
www.heska.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/heska-to-participate-in-the-41st-jp-morgan-annual-healthcare-conference-301708831.html
SOURCE Heska Corporation